Neonatal lupus and related autoimmune disorders of infants

NeoReviews

Volumn 9, Issue 5, 2008, Pages

  Frankovich, Jennifer ^a   Sandborg, Christy ^a   Barnes, Pat ^a   Hintz, Susan ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 45149110782     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.9-5-e206     Document Type: Article

References (59)

1. Chakravarry EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192: 1897-1904
2. Malek A, Sager R, Kuhn P, Nicolaides KY, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996;36:248-255
3. Tran HB, Macardle PJ, Hiscock J et al. Anti-La (SS-B) antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum. 2002;46: 1572-1579
4. Clancy RM, Buyon JP. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block. Rheum Dis Clin North Am. 2004;30:589-602
5. Hariharan D, Manno CS, Seri I. Neonatal lupus erythematosus with microvascular hemolysis. J Pediatr Hematol Oncol. 2000;22: 351-354
6. Cimaz R, Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am. 2006;32:553-573
7. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003;142:678-683
8. Lee IA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics. 2002;109:E11
9. Laxer RM, Roberts EA, Gross KR, et al. Liver disease in neonatal lupus erythematosus. J Pediatr. 1990;116:238-242
10. Buyon JP, Waltuck J, Caldwell K, et al. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block. J Rheumatol. 1994'21:1943-1950
11. Salomonsson S, Sonesson SE, Ottoson L, et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med. 2005;201:11-17
12. Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep. 2007;9:101-108
13. Buyon JP, Clancy RM. Neonatal lupus: basic research and clinical perspective. Rheum Dis Clin North Am. 2005;31:299-313
14. Buyon, JP, Mebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658-1666
15. Brucato A, Doria A, Frassi M, et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus. 2002;11:716-721
16. Moak JP, Barron KS, Hougen TJ, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated. sequela. J Am Coll Cardiol. 2001;37:238-242
17. Tseng CE, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 1997;23:31-54
18. Groves AM, Allan LD, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation. 1995;92:3394-3396
19. Askanase AD, Friedman DM, Copel J, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/ La antibodies. Lupus. 2002;11:145-151
20. Chunharas A, Nuntnarumit P, Hongeng S, Chaunsumrit A. Neonatal lupus erythematosus: clinical manifestations and management. J Med Assoc Thai. 2002;85 (suppl 4):S1302-S1308
21. Nield LE, Silverman ED, Taylor GP, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation. 2002;105:843-848
22. Gladman G, Silverman ED, Yuk L, et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol. 2002;19:73-80
23. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. 1999;42:2335-2345
24. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation. 2004;110:1542-1548
25. Breur JM, Viser GH, Kruize AA, Soutcnbeek P, Meijboom EJ. Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol. 2004;24:467-472
26. Deloof E, Deviieger H, Van Hoestenberghe R, Van den Berghe Y,, Daenen W, Gewillig M. Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr. 1997;156:521-523
27. Carpenter RJ Jr, Strasburger JF, Garson A Jr, Smith RT, Deter RL, Engelhardt HT Jr. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol. 1986;8: 1434-1436
28. van der Leij JN, Visser GH, Bink-Boelkens MT, Meilof JF, Kallenberg CG. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn. 1994;14:1003-1007
29. Wong JP, Kwek KY, Tan JY, Yeo GS. Fetal congenital complete heart block: prophylaxis with intravenous gammaglobulin and treatment with dexamahasone. Aust NZJ Obstet Gynaecol. 2000; 41:339-341
30. Kaaja R, Julkunen H. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum. 2003;48:280-281; author reply 281-282
31. Tsai YG, Ou TY, Want CC, Tasi MC, Yuh YS, Hwang B. Intravenous gamma-globulin therapy in myocarditis complicated with complete heart block: report of one case. Acta Paediatr Taiwan. 2001;42:311-313
32. Lam C, Imundo L, Hirsch D, Yu Z, D'Agati V. Glomerulonephritis in a neonate with atypical congenital lupus and toxoplasmosis. Pediatr Nephrol. 1999;13:850-853
33. Massengill SF, Richard GA, Donnelly WH. Infantile systemic lupus erythematosus with onset simulating congenital nephrotic syndrome. J Pediatr. 1994;124:27-31
34. Morton RL, Moore C, Coventry S, Langston C, Schikler K, Eid NS. Pulmonary capillaritis and hemorrhage in neonatal lupus erythematosus (NLE). J Clin Rheumatol. 2004;10:130-133
35. Kreindler J Ellis D, Vats A, Kurland G, Ranganathan S, Moritz ML. Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage. Pediatr Nephrol. 2005;20:522-525
36. Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005;38:247-255
37. Dallas JS. Autoimmune thyroid disease and pregnancy: relevance for the child. Autoimmunity. 2003;36:339-350
38. Spence D, Hornberger L, Hamilton R, Silverman ED. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies. J Rheumatol. 2006;33:167-170
39. Teyssier G, Gautheron V, Absi L, Galambrun C, Ravni C, Lepetit JC. Anticardiolipin antibodies, cerebral ischemia and adrenal hemorrhage in a newborn infant [in French]. Arch Pediatr. 1995;2:1086-1088
40. Shanske AL, Bernstein L, Herzog R, Chondrodysplasia punctata and maternal autoimmune disease: a new case and review of the literature. Pediatrics. 2007;120:e436-e441
41. Prendiville JS, Cabral DA, Poskitt KJ, Au S, Sargent MA. Central nervous system involvement in neonatal lupus erythematosus. Pediatr Dermatol. 2003; 20:60-67
42. Wang HS, Kuo MF, Chang TC. Sonographic lenticulostriate vasculopathy in infants: some associations and a hypothesis. AJNR Am J Neuroradiol. 1995;16:97-102
43. Zuppa AA, Gallini F, De Luca D, et al. Cerebral ultrasound findings in neonatal lupus syndrome. Biol Neonate. 2004;86:230-234
44. Inoue Y, Fukushige J, Ohno T, Igarashi H, Hara T. Central nervous system vasculopathy associated with neonatal lupus. Pediatr Neurol. 2002;26:68-70
45. Cabanas F, Pellicer A, Valverde E, Morales C, Quero J. Central nervous system vasculopathy in neonatal lupus erythematosus. Pediatr Neurol. 1996;15:124-126
46. Boros CA, Spence D, Blaser S, Silverman ED. Hydrocephalus and macrocephaly: new manifestations of neonatal lupus erythematosus. Arthritis Rheum. 2007;57:161-266
47. Nakayama-Furukawa F, Takigawa M, Iwatsuki K, Sato N, Sato H. Hydrocephalus in two female siblings with neonatal lupus erythematosus. Arch Dermatol. 1994;130:1210-1212
48. Rider LG, Sherry DD, Glass ST. Neonatal lupus erythematosus simulating transient myasthenia gravis at presentation. J Pediatr. 1991;118:417-419
49. Mittendorf R, Covert R, Pryde PG, Lee KS, Ben-Ami T, Yousefzadeh D. Association between lenticulostriate vasculopathy (LSV) and neonatal intraventricular hemorrhage (IVH). J Peritol. 2004;24:700-705
50. Chapman J, Shoenfeld Y. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. Ann N Y Acad Sci. 2002;966:415-424
51. Shoenfeld Y, Nahum A, Korczyn AD, et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus. 2003;12:436-442
52. Katzav A, Chapman J, Shoenfeld Y. CNS dysfunction in the antiphospholipid syndrome. Lupus. 2003;12:903-907
53. Kent M, Akvarez F, Vogt E, Fyffe R, Ng AY, Rote N. Monoclonal antiphosphatidylserine antibodies react directly with feline and murine central nervous system. J Rheumatol. 1997;24:1725-1733
54. Izmirly PM, Rivera TL, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin North Am. 2007;33:267-285
55. Kowal C, Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA. 2006;103:19854-19859
56. Husebye ES, Sthoeger ZM, Dayan M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis. 2005; 64:1210-1213
57. Neri F, Chimini L, Bonomi F. et al. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus. 2004;13:805-811
58. Wang HS, Kuo MF. Sonographic lenticulostriate vasculopathy in infancy with tic and other neuropsychiatric disorders developed after 7 to 9 years of follow-up. Brain Dep. 2003;25(suppl 1):S43-S47
59. Hermachandra AH, Oravec D, Collin M, Tafari N. Mhanna MJ. Early and late postnatal identification of isolated lenticulostriate vasculopathy in preterm infants: associated findings. J Perinatol. 2003;23:20-23